a REIT engaged in the acquisition, ownership & management of industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities
Mkt. Cap: $1.1B;Beta: 2.0
6.44%
2. Village Farms International Inc. (TSX: VFF; Nasdaq: VFF) villagefarms.com
owns and operates agricultural greenhouse facilities exporting its products exclusively to the U. S.
a health and wellness products company engaged in extraction, purification, and formulation of value-added products for both recreational and pet nutrition use
an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus
a vertically integrated cannabis health and wellness company operating 3 product and cultivation facilities and a national network of medical cannabis clinics
cultivates and sells medicinal and recreational cannabis in more than 20 countries through medical cannabis exporting agreements or cultivation facilities
cultivates and sells medical and recreational cannabis in Canada; sells CBD products in the U.S.; exports medical cannabis globally from its production facilities in Canada and Portugal and has a partnership with AB InBev to develop cannabis-infused drinks
Mkt. Cap: $4.1B; Beta: 4.2
2.68%
16. The Green Organic Dutchman Holdings Ltd. (TSX: TGOD, OTCQX: TGODF) www.tgod.ca
a cannabinoid-based research & development company in Canada that produces and distributes cannabis and hemp-related products for medical applications
Mkt. Cap: $913.7M;Beta: 5.0
2.54%
17. Supreme Cannabis Company Inc. (TSX: FIRE) www.supreme.ca
a globally diversified portfolio of 7 distinct cannabis companies, products, and brands
a venture capital company that pursues investment opportunities in the cannabis sector via royalties, joint ventures, secured debt, and other equity/equity-linked instruments
a distributor of vaporizers & parts, cleaning products, grinders & storage containers, pipes, rolling papers and customized lines of premium specialty packaging in the U.S.
a clinical-stage biopharmaceutical company based in Israel
Mkt. Cap: $18.7M; Beta:?
0.24%
Summary of ETF Makeup
Asset Allocation
Common Equity (82%)
Cash Component (18%)
Sector Breakdown
Cultivation/Extraction (55.55%)
Cash Component (17.58%)
Bio-Pharmaceutical (14.04%)
Real Estate (6.44%)
Consumer, Non-Cyclical (4.12%)
Market Cap Breakdown
Micro cap (55%)
Cash Component (18%)
Small cap (15%)
Mid cap (12%)
Country Breakdown
Canada (53%)
United States (47%)
Stock Performance
As can be seen in the chart below The Cannabis ETF has had a rocky start since its launch on May 1st of this year. It is down 22.7% since inception and down 8.4% alone since August 13th.
Conclusion
It is my contention that this ETF is anything but a pure-play in the cannabis sector given its preponderance of biopharmaceutical companies (6), distributors (3), a REIT (1) and a venture capital company (1) representing 26.87% weighting in the ETF and the current 17.58% currently in cash. That leaves only 55.55% operating in the growing, production, extraction and sale of cannabis.
.webp)
Comments
Log in or sign up to join the conversation.